Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

What Do We Want to See in Brain Imaging?

What Do We Want to See in Brain Imaging?

Monday, December 3, 2007 - Tuesday, December 4, 2007

The Royal Institute of British Architects

Presented By

Presented by the New York Academy of Sciences, Imperial College London, King's College London and University College London


Conference supported by GlaxoSmithKline and the Royal Institution of Great Britain.

This symposium will address neuroimaging in the context of a progression from genes to molecules, molecules to cells, cells to organs and organs to systems. It will provide a forum for discussions regarding future directions in brain imaging. The goals of this symposium are:

  • To review the most exciting developments in neuroimaging – from molecules to systems.
  • To highlight the recent work done in this field in the world renowned laboratories.
  • To identify some of the most exciting young investigators in this field.
  • To forge important collaborations between US-based scientists and investigators, which will promote scientific research and cooperation among the various institutions.
  • To disseminate the insights of the meeting to a broad audience via a powerful array of online outlets.

This program is supported by AstraZeneca, Canon, GlaxoSmithKline, Imperial College London, Intra-cellular Therapies, Inc.(ITI), King's College London, S